Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

March 1, 2023

Conditions
Lung NeoplasmsEsophageal Lesion
Interventions
DEVICE

Olympus VE2 NIR Imaging System

A prospective, (NSR), single-center feasibility study of the Olympus VE2 NIR Imaging System to assess perfusion using NIR during minimally invasive esophagectomy or pulmonary segmentectomy based on treatment arm.

DRUG

Indocyanine green

intravenous delivery of low-dose 0.15 mg/kg of ICG combined with Olympus VE2 NIR Imaging System to assess perfusion using NIR during minimally invasive esophagectomy or pulmonary segmentectomy based on treatment arm

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Olympus

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT05346380 - Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download | Biotech Hunter | Biotech Hunter